LeMaitre Vascular (LMAT)
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
$80.67+0.22%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
QuarterlyIQ Insights · LMAT
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 12.9% |
| Our one-year growth estimate | diamond | 11.7% |
Growth built into the price is above our model estimate.
The price assumes 1.2 percentage points more one-year growth.
The one-year revenue growth assumption on Valuation.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Model as of 2026-09-04 · Compared with 25 industry peers · Company calendar date is not available
LMAT — earnings miss
Dated 2026-08-04
Results of Operations and Financial Condition. On August 4, 2026, LeMaitre Vascular, Inc. (the “Company”) issued a press release regarding its preliminary financial and operational results for the quarter ended June 30, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Report. The information in this Item 2.02, including Exhibit 99.1 attached hereto, is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 19…
Why it matters: A drop below this level would suggest rising costs or pricing pressures. This could impact overall profitability.
Worry ifQ2 2026 gross margin reported below 72.1%.
Less concerning ifQ2 2026 gross margin reported above 72.3%.
Why it matters: Falling below this level would make it hard for management to boost income.
Worry ifOperating income in Q3 drops below $17.3mm.
Less concerning ifOperating income is over $18.8mm. This supports ongoing growth.
Why it matters: Changes can affect strategy and management. This may impact investor trust.
Watch forAnnouncement of a new director or board member.
Also watch forNo new appointments or further departures from the Board.
Why it matters: Meeting this growth target would show LeMaitre is on track with its revenue goals. It would also help offset recent earnings concerns.
Supportive ifQ2 revenue growth meets or exceeds 10% year over year.
Worry ifQ2 revenue growth falls below 5% year over year.
Why it matters: Better margins show good cost control. This helps increase operating income.
Supportive ifOperating income margin is over 27% in Q2.
Worry ifOperating income margin drops below 25% in Q2.
Why it matters: Updates on share buybacks may show management's trust in the stock's value.
Supportive ifThey announced share buybacks worth over $25 million.
Worry ifNo updates or repurchases reported by the end of Q2 2026.
Why it matters: A drop below median growth would signal a slowdown in the sector's expansion.
Worry ifRevenue growth falls below the median of 10% year over year.
Less concerning ifRevenue growth remains at or above the median of 10% year over year.
Why it matters: An increase would signal strong cash flow and commitment to returning value to shareholders.
Supportive ifManagement announced they will raise the dividend to more than $0.25 per share.
Worry ifNo dividend increase shows there may be cash flow issues.
Why it matters: Meeting or beating guidance shows strong revenue growth. It matches what management wants.
Supportive ifQ3 2026 sales reported at or above $67.3 million.
Worry ifQ3 2026 sales reported below $66.3 million.
Why it matters: Strong growth in Artegraft sales helps with international expansion. It shows the product launch is successful.
Supportive ifArtegraft sales growth reported above 30% year over year.
Worry ifArtegraft sales growth reported below 20% year over year.
Why it matters: Meeting or beating this guidance shows good cost management. It helps profit growth.
Supportive ifOperating income is at least $18.1 million.
Worry ifOperating income is less than $17.3 million.
Why it matters: Changes to the dividend can show management's confidence. It reflects cash flow and financial health.
Watch forQuarterly dividend is $0.25 or more.
Also watch forQuarterly dividend is less than $0.25.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$134 on $10,000 · ±1.3% | How much price usually moves either way. |
| Bad day | $312 loss on $10,000 · 3.1% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $3,273 loss on $10,000 · 32.7% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.